Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Vaccinia virus-based SARS-CoV-2 vaccine prevents lung immunopathology without antibody-dependent enhancement in female rhesus macaques.
Journal: Virology
Published: May 17, 2025
Long-term efficacy of an inactivated H5N1 whole-particle influenza vaccine in nonhuman primates.
Journal: NPJ vaccines
Published: March 13, 2025
Flavivirus-based bivalent nanoparticle vaccines induce neutralizing antibodies and Th1 responses against flavivirus and coupling antigens.
Journal: iScience
Published: February 21, 2025
Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant.
Journal: iScience
Published: January 18, 2025
Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques.
Journal: Virology
Published: November 17, 2023
SARS-CoV-2 induces inflammation and intracranial infection through the olfactory epithelium-olfactory bulb pathway in non-human primates.
Journal: Journal of neuroimmunology
Published: October 15, 2023
Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19.
Journal: Cell stem cell
Published: November 01, 2022
An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants.
Journal: Frontiers in microbiology
Published: June 12, 2022
Last Updated: 09/26/2026